Law Practice
Nov. 5, 2008
Justices Weigh Pre-emption of State Drug Claims
The U.S. Supreme Court appeared to be leaning toward a narrow ruling in a key case argued Monday about whether state tort claims against drug manufacturers are pre-empted by federal labeling regulations.
Daily Journal Staff Writer WASHINGTON - The U.S. Supreme Court appeared to be leaning toward a narrow ruling in a key case argued Monday about whether state tort claims against drug manufacturers are pre-empted by federal labeling regulations. In what is one of the major cases of the term, the justices are weighing whether plaintiffs can file suit against drug companies in state court over pharmaceutical products if...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In